Crosstalk between B16 melanoma cells and B-1 lymphocytes induces global changes in tumor cell gene expression

Autor(es)

Xander, Patricia ^[1] ; Novaes e Brito, Ronni Romulo ^[2] ; Perez, Elizabeth Cristina ; Pozzibon, Jaqueline Maciel ^[3] ; de Souza, Camila Ferreira ^[4] ; Pellegrino, Renata ^[5] ; Bernardo, Viviane ^[6] ; Jasiulionis, Miriam Galvonas ^[4] ; Mariano, Mario ^[3] ; Lopes, Jose Daniel ^[3]

Afiliação do(s) autor(es)

^[1] Univ Fed Sao Paulo, Dept Ciencias Biol, Campus Diadema - Brazil

^[2] Ctr Univ Sao Camilo, Sao Paulo - Brazil

^[3] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023900 Sao Paulo - Brazil

^[4] Univ Fed Sao Paulo, Dept Farmacol, BR-04023900 Sao Paulo - Brazil

^[5] Univ Fed Sao Paulo, Dept Psicobiol, BR-04023900 Sao Paulo - Brazil

^[6] Univ Fed Sao Paulo, Dept Informat Saude, BR-04023900 Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: Immunobiology; v. 218, n. 10, p. 1293-1303, OCT 2013.
• Citações Web of Science: 8

Resumo

The analysis of gene expression patterns in cancers has improved the understanding of the mechanisms underlying the process of metastatic progression. However, the acquisition of invasive behavior in melanoma is poorly understood. In melanoma, components of the immune system can contribute to tumor progression, and inflammatory cells can influence almost all aspects of cancer progression, including metastasis. Recent studies have attributed an important role to B-1 cells, a subset of B lymphocytes, in melanoma progression. In vitro interactions between B16 melanoma cells and B-1 lymphocytes lead to increased B16 cell metastatic potential, but the molecular changes induced by B-1 lymphocytes on B16 cells have not yet been elucidated. In this study, we used a microarray approach to assess the gene expression profile of B16 melanoma cells following contact with B-1 lymphocytes (B16B1). The microarray analysis identified upregulation in genes involved with metastatic progression, such as ctss, ccl5, cxcl2 and stat3. RT-qPCR confirmed this increase in mRNA expression in B16B1 samples. As previous studies have indicated that the ERK1/2 MAPK cascade is activated in melanoma cells following contact with B-1 lymphocytes, RT-qPCR was performed with RNA from melanoma cells before and after contacting B-1 cells and untreated or treated with ERK phosphorylation inhibitors. The results showed that the expression of stat3, ctss and cxcl2 increased in B16B1 but decreased following ERK1/2 MAPK inhibition. Ccl5 gene expression increased after contacting B-1 cells and was maintained at the same level following inhibitor treatment. Stat3 was verified and validated at the protein level by Western blot analysis. STAT3 expression was also significantly increased in B16B1, suggesting that this pathway can also contribute to the increased metastatic phenotype observed in our model. These results indicated that B-1 cells induce important global gene expression changes in B16 melanoma cells. We also evaluated the relationship of some of the genes identified as differentially expressed and the ERK1/2 MAPK cascade. This work may have important implications for understanding the role of B-1 lymphocytes and the ERK/MAPK cascade in the metastatic process. (C) 2013 Elsevier GmbH. All rights reserved. (AU)

• Processo FAPESP: 07/50521-6 - Analise da expressao diferencial de genes em modelos de transformacao maligna de melancocito murino.
• Beneficiário: Patricia Xander Batista
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 07/51501-9 - Células B-1 e sua participação nos modelos experimentais de melanoma murino e infecção por Paracoccidioides brasiliensis
• Beneficiário: José Daniel Lopes
• Modalidade de apoio: Auxílio à Pesquisa - Temático